The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.
Department of Communications and New Media, National University of Singapore, Singapore, Singapore.
JMIR Hum Factors. 2023 Oct 30;10:e48476. doi: 10.2196/48476.
Physicians play a key role in integrating new clinical technology into care practices through user feedback and growth propositions to developers of the technology. As physicians are stakeholders involved through the technology iteration process, understanding their roles as users can provide nuanced insights into the workings of these technologies that are being explored. Therefore, understanding physicians' perceptions can be critical toward clinical validation, implementation, and downstream adoption. Given the increasing prevalence of clinical decision support systems (CDSSs), there remains a need to gain an in-depth understanding of physicians' perceptions and expectations toward their downstream implementation. This paper explores physicians' perceptions of integrating CURATE.AI, a novel artificial intelligence (AI)-based and clinical stage personalized dosing CDSSs, into clinical practice.
This study aims to understand physicians' perspectives of integrating CURATE.AI for clinical work and to gather insights on considerations of the implementation of AI-based CDSS tools.
A total of 12 participants completed semistructured interviews examining their knowledge, experience, attitudes, risks, and future course of the personalized combination therapy dosing platform, CURATE.AI. Interviews were audio recorded, transcribed verbatim, and coded manually. The data were thematically analyzed.
Overall, 3 broad themes and 9 subthemes were identified through thematic analysis. The themes covered considerations that physicians perceived as significant across various stages of new technology development, including trial, clinical implementation, and mass adoption.
The study laid out the various ways physicians interpreted an AI-based personalized dosing CDSS, CURATE.AI, for their clinical practice. The research pointed out that physicians' expectations during the different stages of technology exploration can be nuanced and layered with expectations of implementation that are relevant for technology developers and researchers.
医生通过用户反馈和对技术开发者的成长建议,在将新的临床技术整合到护理实践中发挥着关键作用。由于医生是通过技术迭代过程涉及的利益相关者,因此了解他们作为用户的角色可以为正在探索的这些技术的工作方式提供细致入微的见解。因此,了解医生的看法对于临床验证、实施和下游采用至关重要。鉴于临床决策支持系统 (CDSS) 的日益普及,仍然需要深入了解医生对其下游实施的看法和期望。本文探讨了医生对将 CURATE.AI(一种新型基于人工智能的临床阶段个性化剂量计算 CDSS)整合到临床实践中的看法。
本研究旨在了解医生将 CURATE.AI 整合到临床工作中的看法,并收集有关实施基于人工智能的 CDSS 工具的考虑因素的见解。
共有 12 名参与者完成了半结构化访谈,内容涉及他们对个性化联合治疗剂量计算平台 CURATE.AI 的知识、经验、态度、风险和未来发展的看法。访谈进行了录音,并逐字转录,然后手动编码。对数据进行了主题分析。
通过主题分析,共确定了 3 个广泛的主题和 9 个子主题。这些主题涵盖了医生在新技术开发的各个阶段(包括试验、临床实施和大规模采用)认为重要的考虑因素。
该研究阐述了医生如何将基于人工智能的个性化剂量计算 CDSS CURATE.AI 应用于他们的临床实践。研究指出,医生在技术探索的不同阶段的期望可能是细微的,并且与实施相关的期望可以分层,这对于技术开发者和研究人员来说是相关的。